{"schema_version":"secwatch.filing_event.v1","accession":"0001739104-24-000036","form_type":"8-K","ticker":"ELAN","cik":"0001739104","company_name":"Elanco Animal Health Inc","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.415497+00:00","generated_at":"2026-05-30T03:40:31.706341+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elanco Q3 revenue $1.03B, +1% organic; adj. EPS $0.13; 2024 guidance tightened","bullets":["Reported net income $364M ($0.73 EPS) includes $640M pre-tax gain from July aqua divestiture; adjusted net income $66M ($0.13 EPS).","Full-year 2024 guidance tightened: revenue $4.42-$4.45B, adj. EBITDA $900-$930M, adj. EPS $0.89-$0.95 (midpoint unchanged).","U.S. FDA approved Zenrelia (JAK inhibitor for atopic dermatitis in dogs) and Credelio Quattro (broad-spectrum parasiticide).","Net leverage ratio 4.3x, down from 5.6x at June 30; aided by aqua divestiture proceeds and debt paydown.","Pet health revenue $486M (-2% organic); Farm animal $530M (+3% organic); cattle up 6% on Experior and Rumensin."],"urls":{"canonical":"https://secwatch.observer/filing/0001739104-24-000036","json":"https://secwatch.observer/filing/0001739104-24-000036.json","markdown":"https://secwatch.observer/filing/0001739104-24-000036.md","text":"https://secwatch.observer/filing/0001739104-24-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739104/000173910424000036/0001739104-24-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739104/000173910424000036/elan-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:40:31.706341+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}